Table 2.
Cumulative incidence of 4-year WLT by patient characteristics and ESKD network and era (n=1,309,998)
| Patient Characteristics | Year of ESKD Onseta | ||||
|---|---|---|---|---|---|
| 1997–2000 | 2001–2004 | 2005–2008 | 2009–2012 | 2013–2016 | |
| Age at ESKD onset | |||||
| 18–39 (11.8%) | 55.8 | 54.4 | 53.4 | 52.0 | 48.8 |
| 40–49 (16.4%) | 41.4 | 39.8 | 40.3 | 40.9 | 38.4 |
| 50–59 (29.3%) | 30.7 | 30.2 | 31.0 | 30.4 | 28.6 |
| 60–70 (42.5%) | 13.4 | 16.3 | 19.7 | 20.5 | 19.8 |
| Race/ethnicity | |||||
| Non-Hispanic White (46.1%) | 32.7 | 31.9 | 32.1 | 30.4 | 28.3 |
| Non-Hispanic Black (32.2%) | 22.9 | 23.2 | 25.3 | 25.9 | 24.4 |
| Asian (3.1%) | 45.3 | 49.3 | 48.9 | 49.4 | 47.4 |
| Hispanic White (14.6%) | 31.7 | 32.5 | 34.3 | 33.8 | 30.8 |
| Hispanic Black (0.5%) | 27.7 | 29.2 | 31.6 | 26.7 | 29.2 |
| Other (3.6%) | 23.7 | 25.4 | 28.3 | 27.0 | 24.7 |
| Sexb | |||||
| Women (43.0%) | 25.9 | 26.5 | 28.0 | 27.5 | 25.5 |
| Men (57.0%) | 31.8 | 31.5 | 32.5 | 31.9 | 30.0 |
| Primary diagnosis | |||||
| Diabetes (49.1%) | 22.4 | 23.0 | 25.0 | 24.8 | 22.1 |
| Hypertension (22.8%) | 26.7 | 26.8 | 28.0 | 28.1 | 27.1 |
| GN (11.1%) | 51.8 | 52.5 | 54.6 | 54.5 | 52.0 |
| Cystic disease (3.1%) | 67.4 | 70.9 | 72.9 | 71.8 | 69.8 |
| Other (14.0%) | 25.5 | 25.5 | 25.5 | 25.0 | 26.5 |
| BMI, kg/m2b | |||||
| 13–18 (2.9%) | 23.2 | 21.1 | 21.8 | 23.7 | 20.1 |
| 19–24 (21.1%) | 29.6 | 30.1 | 31.3 | 30.8 | 29.7 |
| 25–29 (27.9%) | 32.1 | 32.9 | 34.6 | 34.6 | 32.4 |
| 30–34 (20.3%) | 30.4 | 31.7 | 34.7 | 34.3 | 32.7 |
| 35–39 (11.8%) | 26.1 | 27.4 | 30.1 | 30.2 | 28.1 |
| 40+ (12.1%) | 19.3 | 17.4 | 17.0 | 16.0 | 13.1 |
| ESKD networkb | |||||
| (S-CA) Southern California network (7.4%) | 31.8 | 33.4 | 31.7 | 29.2 | 29.2 |
| (N-CA) Trans-Pacific ESRD Network (4.7%) | 40.3 | 44.7 | 47.4 | 42.4 | 37.7 |
| (WA) Northwest Renal Network (2.8%) | 35.7 | 33.5 | 31.0 | 29.5 | 27.2 |
| (CO) Inter-Mountain ESRD Network (4.7%) | 32.6 | 30.6 | 32.9 | 33.0 | 30.8 |
| (TX) Network of Texas era (9.1%) | 26.0 | 25.9 | 28.9 | 29.7 | 26.1 |
| (OK) ESRD Network 13 (4.5%) | 22.4 | 19.7 | 21.1 | 20.2 | 19.4 |
| (MO) ESRD Network 12 (3.7%) | 28.6 | 27.4 | 28.8 | 28.0 | 27.6 |
| (MN) Renal Network of Upper Midwest (6.3%) | 37.4 | 38.0 | 36.0 | 34.9 | 34.2 |
| (IL) Renal Network of Illinois era (4.2%) | 31.1 | 30.8 | 32.0 | 33.1 | 29.6 |
| (IN) Tri-State R. N. era (7.4%) | 26.2 | 25.0 | 25.1 | 23.5 | 22.0 |
| (MS) Network 8 era (5.8%) | 24.5 | 25.7 | 26.0 | 26.0 | 21.6 |
| (FL) ESRD Network of Florida (5.9%) | 24.2 | 23.7 | 24.8 | 24.9 | 23.4 |
| (NC) Southeastern Kidney Council (9.4%) | 21.6 | 21.5 | 23.6 | 24.7 | 25.0 |
| (VA) Mid-Atlantic R. C. era (6.1%) | 31.6 | 29.6 | 29.4 | 31.1 | 29.3 |
| (PA) ESRD Network Organization (4.3%) | 32.8 | 33.7 | 36.3 | 34.4 | 34.1 |
| (NJ) Trans-Atlantic R. C. era (4.4%) | 26.3 | 29.4 | 30.9 | 30.7 | 28.7 |
| (NY) Network of New York era (6.2%) | 28.8 | 30.6 | 37.2 | 37.0 | 33.4 |
| (CT) Network of New England era (3.2%) | 35.8 | 37.0 | 40.0 | 40.9 | 38.8 |
| Median household income level, $b | |||||
| <29,000 (8.3%) | 19.3 | 19.1 | 20.2 | 20.8 | 18.4 |
| 29,001–$36,000 (11.8%) | 21.2 | 21.1 | 22.9 | 23.1 | 21.2 |
| 36,001–47,000 (26.9%) | 24.8 | 24.1 | 26.8 | 26.4 | 24.0 |
| 47,001–61,000 (25.6%) | 30.0 | 29.6 | 32.3 | 31.9 | 29.7 |
| 61,001–80,000 (16.0%) | 35.6 | 36.1 | 38.1 | 37.0 | 35.7 |
| >80,000 (9.7%) | 42.7 | 44.1 | 45.5 | 46.0 | 44.0 |
| All patients | 29.1 | 29.3 | 30.6 | 30.1 | 28.1 |
S-CA, Southern California; N-CA, Northern California; R. N., renal network; R. C., renal coalition.
a
Cumulative incidence on the basis of competing risk models with death included as a competing risk; includes patients listed or transplanted preemptively as well as following dialysis initiation.
b
Missing levels are not displayed.